RA Messages for January 15, 2002
PHARMACY PROVIDERS,PLEASE NOTE!!!
PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION OF
APPENDIX C
LABELER |
COMPANY |
BEGIN |
END |
00214 |
GLAXOSMITHKLINE |
04/01/02 |
|
10158 |
GLAXOSMITHKLINE |
04/01/02 |
|
11530 |
GLAXOSMITHKLINE |
04/01/02 |
|
38206 |
NUTRAMAX |
|
01/01/02 |
38779 |
MEDISCA, INC |
04/01/02 |
|
44206 |
ZLB BIOPLASMA, INC |
04/01/02 |
|
57480 |
MEDIREX, INC |
|
01/01/02
|
58865 |
DAWN WHOLESALE PHARMA.,INC |
|
01/01/02
|
59243 |
SAGE PHARMACEUTICALS INC |
01/01/02 |
|
63913 |
MEDICAL MERCHANDISING, INC |
04/01/02 |
|
65976 |
ORAPHARMA |
04/01/02 |
|
74684 |
GLAXOSMITHKLINE |
04/01/02 |
|
PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION OF
APPENDIX A
DRUG |
DOSAGE |
STRGTH |
MAC |
EFF DATE |
AMITRIPTYLINE |
TABLET |
25MG |
0.05480 |
01/22/02 |
ATENOLOL |
TABLET |
25MG |
0.06140 |
01/22/02 |
CHLORTHALIDONE |
TABLET |
50MG |
0.05580 |
01/22/02 |
DEXAMETHASONE |
ELIXIR |
0.5MG/5ML |
0.03960 |
01/22/02 |
DILTIAZEM HCL |
CAP.SR 24HR |
240MG |
OFF MAC |
01/22/02 |
HYDROCOD BIT/HOMATROPINE |
SYRUP |
5-1-.5MG/5 |
0.02800 |
01/22/02 |
HYDROXYZINE HCL |
TABLET |
10MG |
0.05250 |
01/22/02 |
IS0SORBIDE DINITRATE |
TAB SUBL |
5MG |
0.04630 |
09/30/97 |
LOPERAMIDE HCL |
CAPSULE |
2MG |
0.59300 |
09/30/97 |
NADOLOL |
TABLET |
20MG |
0.46500 |
01/22/02 |
NAPROXEN SODIUM |
TABLET |
275MG |
0.14890 |
01/22/02 |
NORTRIPTYLINE HCL |
CAPSULE |
75MG |
0.22030 |
01/22/02 |
NITROGLYCERIN |
PATCH TD 24 |
0.2MG/HR |
1.39883 |
09/30/97 |
NITROGLYCERIN |
PATCH TD 24 |
0.4MG/HR |
1.60000 |
08/31/98 |
NITROGLYCERIN |
PATCH TD 24 |
0.6MG/HR |
OFF MAC |
10/31/99 |
NYSTATIN |
ORAL SUSP |
100MU/ML |
0.00850 |
01/22/02 |
OXAZEPAM |
CAPSULE |
10MG |
0.53630 |
01/22/02 |
OXAZEPAM |
CAPSULE |
15MG |
0.76240 |
01/22/02 |
PERPHENAZINE |
TABLET |
8MG |
O.73600 |
09/30/97 |
PRAZOSIN HCL |
CAPSULE |
1MG |
0.24150 |
09/30/97 |
PRAZOSIN HCL |
CAPSULE |
5MG |
0.57600 |
09/30/97 |
PROPRANOLOL HCL |
TABLET |
20MG |
0.07500 |
01/22/02 |
PROPRANOLOL HCL |
TABLET |
40MG |
0.05900 |
01/22/02 |
THEOPHYLLINE ANHYDROUS |
TAB/SR12H |
100MG |
0.09570 |
01/22/02 |
TRIAMCINOLONE ACETONIDE |
CREAM |
0.1% |
0.04480 |
01/22/02 |
IF YOU ARE UNSURE ABOUT THE
COVERAGE OF A DRUG PRODUCT, PLEASE CONTACT
THE PBM HELP DESK AT 1-800-648-0790.
ATTENTION MEDICAID PROVIDERS
IT HAS COME TO THE DEPARTMENT'S ATTENTION THAT
SOME PROVIDERS ARE SENDING IDENTIFYING INFORMATION OVER THE INTERNET THAT MAY OR
MAY NOT BE ENCRYPTED. DO NOT SEND ANY IDENTIFYING INFORMATION (E.G. NAME, SOCIAL
SECURITY NUMBERS, MEDICAID NUMBERS, ETC.) OVER THE INTERNET UNLESS THIS
INFORMATION IS ENCRYPTED.
LONG TERM CARE PROVIDERS
DUE TO PROCEDURAL CHANGES, A PRIVATE
CONTRACTOR, BENOVA, WILL BEGIN TAKING LONG TERM CARE APPLICATIONS EFFECTIVE
JANUARY 2, 2002. THIS WILL IN NO WAY AFFECT THE METHOD OF DETERMINING
MEDICAID ELIGIBILITY FOR LONG TERM CARE APPLICANTS.
EFFECTIVE JANUARY 2, 2002, ALL REQUESTS FOR
LONG TERM CARE APPLICATIONS SHOULD BE REFERRED TO BENOVA AT 1-877-456-1146 FOR
PROCESSING. INVOICES FOR PAYMENT SHOULD BE SUBMITTED BY MARCH 15, 2002.
ANY REQUESTS FOR REIMBURSEMENT MADE AFTER THIS DATE WILL NOT BE PAID.
VISION SERVICES AND EYE CARE PROGRAM
PROVIDERS
CLARIFICATION OF SAME DAY/SUBSEQUENT DAY FOLLOW-UP OFFICE VISIT POLICY
A SEPARATE SAME DAY OR SUBSEQUENT DAY FOLLOW-UP OFFICE VISIT IS ALLOWED
FOR THE PURPOSE OF THE DELIVERY,AND FINAL ADJUSTMENT TO THE VISUAL AXES AND ANATOMICAL TOPOGRAPHY OF MEDICAID-COVERED EYEGLASSES, CATARACT
GLASSES, OR CONTACT LENSES.PRESENCE OF THE PHYSICIAN IS NOT REQUIRED.IF THE VISIT MEETS THESE CRITERIA, THE PROVIDER SHOULD BILL PROCEDURE CODE
99211. DOCUMENTATION IN THE PATIENT'S RECORD SHOULD REFLECT THAT THE PATIENT RETURNED FOR A SEPARATE VISIT ON THE SAME DAY OR SUBSEQUENT DAY
FOR THE PURPOSE OF THE DELIVERY, AND FINAL ADJUSTMENT OF THE EYE WEAR, AND MUST INCLUDE A DESCRIPTION OF THE SERVICES PROVIDED. IF THE PATIENT
RETURNS ON THE SAME DAY OR SUBSEQUENT DAY SIMPLY TO PICK UP THEIR EYE WEAR, AND NO FINAL ADJUSTMENTS TO THE VISUAL AXES, AND ANATOMICAL
TOPOGRAPHY ARE PERFORMED, THE PROVIDER MUST NOT BILL FOR THIS SERVICE. SHOULD YOU HAVE ANY FURTHER QUESTIONS REGARDING THIS POLICY, YOU MAY
CONTACT UNISYS PROVIDER RELATIONS BY CALLING 1-800-473-2783.
ATTENTION ALL MEDICAID PROVIDERS
PROVIDERS WHO WANT TO DRAW THE ATTENTION OF A
REVIEWER TO A SPECIFIC PART OF A REPORT OR ATTACHMENT ARE ASKED TO CIRCLE THAT
PARTICULAR PARAGRAPH OR SENTENCE.